Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases—focusing on FAAH/MAGL inhibitors
Crossref DOI link: https://doi.org/10.1038/s41401-020-0385-7
Published Online: 2020-03-18
Published Print: 2020-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ren, Si-yu
Wang, Zhen-zhen
Zhang, Yi
Chen, Nai-hong
Text and Data Mining valid from 2020-03-18
Version of Record valid from 2020-03-18
Article History
Received: 10 December 2019
Revised: 15 February 2020
Accepted: 19 February 2020
First Online: 18 March 2020
Competing interests
: The authors declare no competing interests.